Please see annexed enclosure.

September 15, 2026 To To The Corporate Relations Department The Listing Department BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Code: 540222 Code: LAURUSLABS Subject: Intimation of Schedule of Analyst / Institutional Investor Meeting pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company will be participating in the following Investors Conference in in one-on-one meetings and group meetings. Date Analyst / Investors / Event Place Type of Interaction September 22- Goldman Sachs Global Healthcare CDMO Day Singapore In-Person Meetings 24, 2026 Note: 1. Date of the aforesaid meeting is subject to change due to exigencies on the part of Investor(s) / Company. 2. No Unpublished Price Sensitive Information will be shared during the meeting. We request you to please take the same on record. Thanking You, Yours faithfully, For Laurus Labs Limited G. Venkateswar Reddy Company Secretary & Compliance Officer